Strong Revenue Growth
Total as-reported revenue grew 10% year-over-year with a 9% increase in constant currency organic revenue, driven by volume and pricing improvements.
Improved Gross and EBIT Margins
Gross margin increased 60 basis points to 44.3%, and EBIT margin improved by 90 basis points to 23.1%, driven by positive pricing, productivity, and operating expense leverage.
Significant Growth in Earnings Per Share
Adjusted earnings per diluted share from continuing operations were $2.47, representing a 15% increase over the prior year.
Strong Performance in AST Services
AST segment saw a 7% growth in constant currency organic revenue with 13% growth in services, driven by stable medical device volumes and bioprocessing demand.
Healthcare Segment Success
Healthcare saw 9% growth in constant currency organic revenue, with service growing 13% and consumables by 10%. EBIT margins increased by 100 basis points.
Positive Outlook for Fiscal 2026
The outlook for fiscal 2026 has been increased, with expectations of 8% to 9% as-reported revenue growth and a free cash flow outlook raised by $30 million to $850 million.